EZZ Life Science Holdings Limited (EZZ.AX)
- Previous Close
0.8850 - Open
0.8850 - Bid 0.8600 x --
- Ask 0.9000 x --
- Day's Range
0.8100 - 0.9000 - 52 Week Range
0.4500 - 0.9150 - Volume
73,753 - Avg. Volume
60,624 - Market Cap (intraday)
39.972M - Beta (5Y Monthly) 0.66
- PE Ratio (TTM)
11.25 - EPS (TTM)
0.0800 - Earnings Date --
- Forward Dividend & Yield 0.02 (2.70%)
- Ex-Dividend Date Oct 30, 2023
- 1y Target Est
--
EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally. The company operates in two segments, Brought in Lines and Company Owned Products. It is also involved in the wholesale distribution of the EAORON branded skin care products to retailers; and research and development, and sale of genomics and precision nutrition research products under the EZZ brand. The company also offers its products online. EZZ Life Science Holdings Limited was incorporated in 2015 and is based in Silverwater, Australia.
ezzlife.com.auRecent News: EZZ.AX
Performance Overview: EZZ.AX
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EZZ.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EZZ.AX
Valuation Measures
Market Cap
39.97M
Enterprise Value
27.66M
Trailing P/E
11.06
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.88
Price/Book (mrq)
2.61
Enterprise Value/Revenue
0.63
Enterprise Value/EBITDA
5.55
Financial Highlights
Profitability and Income Statement
Profit Margin
7.94%
Return on Assets (ttm)
15.56%
Return on Equity (ttm)
24.87%
Revenue (ttm)
43.73M
Net Income Avi to Common (ttm)
3.47M
Diluted EPS (ttm)
0.0800
Balance Sheet and Cash Flow
Total Cash (mrq)
12.62M
Total Debt/Equity (mrq)
1.99%
Levered Free Cash Flow (ttm)
3.31M
Company Insights: EZZ.AX
EZZ.AX does not have Company Insights